Search Results 1531-1540 of 19457 for Hemoglobin

  1. Neurology - Clinical trials - Mayo Clinic

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

  2. Neurology - Clinical trials - Mayo Clinic

    In addition to belonging to one of these 16 subcohorts, patients will be required to have bloodwork demonstrating a blood hemoglobin ≥ 10 g/dL, a ...

  3. A Study to Compare the Effectiveness, Safety and Tolerability of P1101 vs. Anagrelide for Essential Thrombocythemia - Mayo Clinic

    ... hemoglobin (HGB) <10 g/dL at any dose and any duration of HU, or Presence of HU-related toxicities at any dose and any duration of therapy (e.g., leg ulcers ...

  4. Advanced Hybrid Closed Loop (AHCL) System in Type 1 Adult and Pediatric Subjects Utilizing Lyumjev® Insulin Lispro-aabc - Mayo Clinic

    Has a Glycosylated hemoglobin (HbA1c) less than 10% (as processed by Central Lab) at time of screening visit. Note: All HbA1c blood specimens will be sent ...

  5. A Study of Intratumoral Injection of Autologous Dendritic Cells after High-Dose Conformal External Beam Radiotherapy in Patients with Unresectable Liver Cancer - Mayo Clinic

    Hemoglobin ≥9.0 g/dL;; Total bilirubin <3 mg/dL;; Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) ≤5 x ULN;; Creatinine ≤2 mg/dL;; PT/INR ...

  6. Olaparib, Cediranib Maleate, and Standard Chemotherapy in Treating Patients With Small Cell Lung Cancer - Mayo Clinic

    Hemoglobin >= 10 g/dL; Total bilirubin =< 1.5 x institutional upper limit of normal (ULN); Aspartate aminotransferase (AST) serum glutamic-oxaloacetic ...

  7. Veliparib and Topotecan Hydrochloride in Treating Patients With Solid Tumors, Relapsed or Refractory Ovarian Cancer, or Primary Peritoneal Cancer - Mayo Clinic

    Hemoglobin ≥ 9.0 g/dL;; Platelets ≥ 100,000/mcL;; Total bilirubin ≤ 1.5 x the upper limit of normal (ULN);; SGPT (ALT) or SGOT (AST) ≤ 2.5 x ULN in the ...

  8. Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer - Mayo Clinic

    Patient must have absolute neutrophil count (ANC), platelets, and hemoglobin measured within 28 days prior to randomization. The purpose of these tests is ...

  9. Liposomal Irinotecan, Fluorouracil, Leucovorin Calcium, and Rucaparib in Treating Patients With Metastatic Pancreatic, Colorectal, Gastroesophageal, or Biliary Cancer - Mayo Clinic

    Obtained =< 21 days prior to registration: Hemoglobin > 9.0 g/dL;; Obtained =< 21 days prior to registration: Total bilirubin =< institutional upper limit of ...

  10. Radioembolization With Tremelimumab and Durvalumab for Locally Advanced Unresectable or Oligo-Metastatic Intrahepatic Cholangiocarcinoma - Mayo Clinic

    Hemoglobin ≥ 9.0 g/dL;; Absolute neutrophil count (ANC) ≥1000/mm^3;; Platelet count ≥ 75,000/mm^3;; Total bilirubin ≤ 1.5 x ULN;; Alanine aminotransferase ...